CDK12 Promotes Tumorigenesis but Induces Vulnerability to Therapies Inhibiting Folate One-Carbon Metabolism in Breast Cancer

Researchers showed that transgenic CDK12 overexpression in the mouse mammary gland per se is sufficient to drive the emergence of multiple and multifocal tumors, while, in cooperation with known oncogenes, it promoted earlier tumor onset and metastasis.